TEL AVIV, Israel – May 19, 2022 – Global law firm Greenberg Traurig, P.A. was named “Patent Strategy Law Firm of the Year” by LMG Life Sciences EMEA (Europe, Middle East, and Africa). The recognition was announced at the LMG Life Sciences EMEA 2022 Awards May 12 in London. In addition, the firm was shortlisted as the “Israel Firm of the Year.”
The LMG Life Sciences EMEA Awards recognize complex and innovative legal work in the life sciences sector across 58 practice areas. Recognition is based on extensive research into the EMEA life sciences legal market, submissions, in-depth interviews, and client feedback from the EMEA markets.
According to the publication, LMG Life Sciences is a resource for in-house counsel and the only legal ranking directory to identify the leading law firms and individuals in the life sciences industry through deep analysis of the business and legal developments in the sector.
Greenberg Traurig’s Israel Life Sciences & Medical Technology Group represents a myriad of Israeli companies with U.S.-focused operations, in connection with their intellectual property (IP), corporate, and compliance needs. The team includes Robert L. Grossman, chair of the Israel Practice and Corporate shareholder; Barry J. Schindler, co-chair of Greenberg Traurig's Global Patent Prosecution Group; Adam Snukal, IP & Technology shareholder; Devora Snyder-Shefer, IP & Technology senior associate; and Dr. Mark Ruberto, patent agent.